{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06075264",
            "orgStudyIdInfo": {
                "id": "ART-VIN IIB"
            },
            "secondaryIdInfos": [
                {
                    "id": "23-889",
                    "type": "OTHER",
                    "domain": "Cleveland Clinic IRB"
                }
            ],
            "organization": {
                "fullName": "Frantz Viral Therapeutics, LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)",
            "officialTitle": "A Phase II Double-blind, Placebo-controlled, Randomized Trial of Topical Artesunate Ointment for the Treatment of Patients With Vulvar High-grade Squamous Intraepithelial Lesions (Vulvar HSIL)",
            "acronym": "ART-VIN IIB",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Infectious Diseases",
                "Other"
            ],
            "study": "phase-ii-study-of-artesunate-ointment-for-the-treatment-of-vulvar-high-grade-squamous-intraepithelial-lesions-vulvar-hsil"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-06",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-04",
            "studyFirstSubmitQcDate": "2023-10-04",
            "studyFirstPostDateStruct": {
                "date": "2023-10-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Frantz Viral Therapeutics, LLC",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "The Cleveland Clinic",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a phase II double-blind, placebo-controlled study of artesunate ointment for the treatment of HPV-associated vulvar HSIL (usual type vulvar intraepithelial neoplasia 2/3).",
            "detailedDescription": "Eligible participants in this study are randomized 2:1 to receive either artesunate or placebo ointment for the treatment of vulvar HSIL. Both groups receive four 5-day cycles of topical ointment, at weeks 0, 2, 4, and 6. Dosing visits may be done in person or as telehealth (ointment may be shipped directly to the patient). Participants are followed closely with vulvar examinations or colposcopies at weeks 8, 18, 6-months and 12-months."
        },
        "conditionsModule": {
            "conditions": [
                "Vulvar Diseases",
                "HPV Infection",
                "Vulvar HSIL",
                "Pre-Cancerous Dysplasia",
                "HPV Disease",
                "VIN, Usual Type",
                "VIN 2 of Usual Type",
                "VIN 3 of Usual Type",
                "Vin II",
                "Vin III",
                "VIN Grade 2",
                "VIN Grade 3",
                "High Grade Intraepithelial Neoplasia"
            ],
            "keywords": [
                "topical treatment",
                "ointment",
                "non-surgical",
                "vulvar cancer prevention",
                "high-risk HPV",
                "human papillomavirus",
                "HPV",
                "vulvar HSIL",
                "High grade lesions"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Double-blind, placebo-controlled randomized trial",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "Double-blind, placebo controlled",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 27,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Artesunate ointment",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Artesunate formulated as topical ointment, 40% Four 5-day cycles of artesunate ointment every 2 weeks",
                    "interventionNames": [
                        "Drug: Artesunate ointment"
                    ]
                },
                {
                    "label": "Placebo ointment",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo ointment Four 5-day cycles of placebo ointment every 2 weeks",
                    "interventionNames": [
                        "Drug: Placebo ointment"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Artesunate ointment",
                    "description": "topical ointment, as a non-surgical treatment",
                    "armGroupLabels": [
                        "Artesunate ointment"
                    ],
                    "otherNames": [
                        "Artesunic acid",
                        "Dihydroartemisinin (DHA)",
                        "Artemisinin"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo ointment",
                    "description": "topical placebo ointment",
                    "armGroupLabels": [
                        "Placebo ointment"
                    ],
                    "otherNames": [
                        "Placebo to artesunate ointment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants with complete histologic response",
                    "description": "Number of participants who have complete histologic response following topical artesunate ointment",
                    "timeFrame": "18 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of participants who have achieved viral clearance",
                    "description": "Number of participants who achieve clearance of HPV genotypes present at screening. These genotypes become undetectable over the study window.",
                    "timeFrame": "Week 18"
                },
                {
                    "measure": "Number of participants who show partial response",
                    "description": "Number of participants with documented partial response following topical artesunate",
                    "timeFrame": "Week 18"
                },
                {
                    "measure": "Number of participants who have durable response",
                    "description": "Number of participants with documented complete response who do not have recurrence of their vulvar HSIL over the study window",
                    "timeFrame": "Week 18"
                },
                {
                    "measure": "Incidence of Treatment-Emergent Adverse Events (TEAE)",
                    "description": "Number of participants who report artesunate-related serious adverse events",
                    "timeFrame": "8 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult women age \u2265 18 years\n* Capable of informed consent\n* Able to collaborate with planned follow-up (transportation, compliance history, etc)\n* Biopsy diagnosis of high-grade vulvar dysplasia (VIN2, VIN3, VIN2/3, HSIL), including both new and recurrent disease. A biopsy diagnosis of vulvar high-grade squamous intraepithelial lesion within the previous 3 months which was not excised or otherwise treated may be accepted for study entry.\n* Positive HPV test at study entry (any genotype).\n* Women of childbearing potential agree to use birth control during the dosing phase (through week 8).\n* Laboratory values at Screening of:\n\n  * Serum alanine transaminase (SGPT/ALT) \\< 5 x upper limit of normal (ULN)\n  * Serum aspartate transaminase (SGOT/AST) \\< 5 x ULN\n  * Serum Bilirubin (total) \\< 2.5 x ULN\n  * Serum Creatinine \u2264 1.5 x ULN\n* Weight \u2265 50kg\n\nExclusion Criteria:\n\n* Pregnant and nursing women\n* Concurrent anal, vulvar, or cervical cancer\n* HIV-positive participants with a CD4 count \\< 200\n* Participants infected with HIV-1 if not on a stable, suppressive antiretroviral therapy (ART) regimen.\n* Unwillingness to undergo an excisional procedure at week 18 to either remove HSIL lesions, or to document histologic regression at a site where HSIL was present at study entry.\n* Currently receiving systemic chemotherapy or radiation therapy for another cancer.\n* Concomitant use of Efavirenz for HIV antiretroviral treatment\n* Concomitant use of strong UGT inhibitors\n* Concomitant use of imiquimod, cidofovir, or 5-fluorouracil (5-FU) for the duration of the study\n* Concurrent dermatological conditions affecting the vulva (e.g., herpetic lesion, Crohn's disease, hidradenitis suppurativa) or vulvar dermatoses (e.g., lichen sclerosis or planus, atopic dermatitis, genital atrophy).\n* Concurrent treatment with systemic corticosteroids",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "This study is only for biological females",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mihaela Plesa",
                    "role": "CONTACT",
                    "phone": "440-255-1155",
                    "email": "fvtinfo@frantzgroup.com"
                },
                {
                    "name": "Ahmad Bayat, MD",
                    "role": "CONTACT",
                    "phone": "301-956-2523"
                }
            ],
            "locations": [
                {
                    "facility": "Florida Gynecologic Oncology",
                    "status": "RECRUITING",
                    "city": "Fort Myers",
                    "state": "Florida",
                    "zip": "33905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Edward C. Grendys, MD FACOG, FACS",
                            "role": "CONTACT",
                            "phone": "239-334-6626",
                            "email": "Edward.Grendys@usa.genesiscare.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.62168,
                        "lon": -81.84059
                    }
                },
                {
                    "facility": "Cleveland Clinic Fairview Hospital",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44111",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Donna White",
                            "role": "CONTACT",
                            "phone": "216-445-8090",
                            "email": "whited11@ccf.org"
                        },
                        {
                            "name": "Megan Park",
                            "role": "CONTACT",
                            "phone": "216-445-8090",
                            "email": "parkm2@ccf.org"
                        },
                        {
                            "name": "Chad Michener, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Mariam AlHilli, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Steven Waggonner, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Robert DeBernardo, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Roberto Vargas, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Cleveland Clinic Foundation",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Donna White",
                            "role": "CONTACT",
                            "phone": "216-445-8090",
                            "email": "whited11@ccf.org"
                        },
                        {
                            "name": "Megan Park",
                            "role": "CONTACT",
                            "phone": "216-445-8090",
                            "email": "parkm2@ccf.org"
                        },
                        {
                            "name": "Chad Michener, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Lindsey Beffa, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Steven Waggonner, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Robert DeBernardo, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Roberto Vargas, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Mariam AlHilli, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Johanna Kelley, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Daniel Margul, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Michelle Kuznicki, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Hillcrest Hospital",
                    "status": "RECRUITING",
                    "city": "Mayfield Heights",
                    "state": "Ohio",
                    "zip": "44124",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Donna White",
                            "role": "CONTACT",
                            "phone": "216-445-8090",
                            "email": "whited11@ccf.org"
                        },
                        {
                            "name": "Megan Park",
                            "role": "CONTACT",
                            "phone": "216-445-8090",
                            "email": "parkm2@ccf.org"
                        },
                        {
                            "name": "Chad Michener, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Mariam AlHilli, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Steven Waggonner, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Robert DeBernardo, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Roberto Vargas, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Lindsey Beffa, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.51922,
                        "lon": -81.4579
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000030361",
                    "term": "Papillomavirus Infections"
                },
                {
                    "id": "D000014845",
                    "term": "Vulvar Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000015229",
                    "term": "Sexually Transmitted Diseases, Viral"
                },
                {
                    "id": "D000012749",
                    "term": "Sexually Transmitted Diseases"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000004266",
                    "term": "DNA Virus Infections"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000014412",
                    "term": "Tumor Virus Infections"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23687",
                    "name": "Papillomavirus Infections",
                    "asFound": "HPV Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17589",
                    "name": "Vulvar Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17588",
                    "name": "Vulvar Diseases",
                    "asFound": "Vulvar Diseases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15558",
                    "name": "Sexually Transmitted Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17933",
                    "name": "Sexually Transmitted Diseases, Viral",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7442",
                    "name": "DNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17162",
                    "name": "Tumor Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "T5877",
                    "name": "Vulvar Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077332",
                    "term": "Artesunate"
                },
                {
                    "id": "C000039060",
                    "term": "Artenimol"
                },
                {
                    "id": "D000037621",
                    "term": "Artemisinins"
                },
                {
                    "id": "C000031327",
                    "term": "Artemisinin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000962",
                    "term": "Antimalarials"
                },
                {
                    "id": "D000000981",
                    "term": "Antiprotozoal Agents"
                },
                {
                    "id": "D000000977",
                    "term": "Antiparasitic Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000012556",
                    "term": "Schistosomicides"
                },
                {
                    "id": "D000000980",
                    "term": "Antiplatyhelmintic Agents"
                },
                {
                    "id": "D000000871",
                    "term": "Anthelmintics"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1769",
                    "name": "Artesunate",
                    "asFound": "Force",
                    "relevance": "HIGH"
                },
                {
                    "id": "M24698",
                    "name": "Artemisinins",
                    "asFound": "Make up",
                    "relevance": "HIGH"
                },
                {
                    "id": "M349055",
                    "name": "Artemisinin",
                    "asFound": "Make up",
                    "relevance": "HIGH"
                },
                {
                    "id": "M189432",
                    "name": "Artenimol",
                    "asFound": "Gonadotropin",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4280",
                    "name": "Antimalarials",
                    "relevance": "LOW"
                },
                {
                    "id": "M4298",
                    "name": "Antiprotozoal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4294",
                    "name": "Antiparasitic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4196",
                    "name": "Anthelmintics",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}